N. Fabre And NotTomoscintigraphie

List of bibliographic references

Number of relevant bibliographic references: 13.

Ident.	Authors (with country if any)	Title
000050	F. Ory Magne [France] ; N. Fabre [France] ; C. Gu [France] ; C. Pastorelli [France] ; S. Tardez [France] ; J.-C. Marchat [France] ; P. Marque [France] ; C. Brefel Courbon [France]	An individual rehabilitation program: Evaluation by Parkinsonian patients and their physiotherapists
001060	O. Rascol [France] ; J. G. Nutt [États-Unis] ; O. Blin [France] ; C. G. Goetz [États-Unis] ; J. M. Trugman [États-Unis] ; C. Soubrouillard [France] ; J. H. Carter [États-Unis] ; L. J. Currie [États-Unis] ; N. Fabre [France] ; C. Thalamas [France] ; W. J. Giardina [États-Unis] ; S. Wright [États-Unis]	Induction by Dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with parkinson Disease
001064	O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
001230	U. Sabatini [France] ; K. Boulanouar [France, Italie] ; N. Fabre [France] ; F. Martin [France] ; C. Carel [France] ; C. Colonnese [Italie] ; L. Bozzao [Italie] ; I. Berry [France] ; J. L. Montastruc [France] ; F. Chollet [France] ; O. Rascol [France]	Cortical motor reorganization in akinetic patients with Parkinson's disease: A functional MRI study
001369	O. Rascol [France] ; O. Blin [France] ; C. Thalamas [France] ; S. Descombes [France] ; C. Soubrouillard [France] ; P. Azulay [France] ; N. Fabre [France] ; F. Viallet [France] ; K. Lafnitzegger [États-Unis] ; S. Wright [États-Unis] ; J. H. Carter [États-Unis] ; J. G. Nutt [États-Unis]	ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's Disease
001498	N. Fabre [France] ; C. Brefel-Courbon [France] ; O. Rascol [France]	Parkinson « plus » : Mouvements anormaux
001523	O. Rascol [France] ; N. Fabre [France] ; J.-L. Montastruc [France]	Fluctuations de la réponse à la L-dopa dans la maladie de Parkinson : Maladie de Parkinson - 2e partie
001733	J.-L. Montastruc [France] ; N. Fabre [France] ; O. Blin [France] ; J.-M. Senard [France] ; O. Rascol [France] ; A. Rascol [France]	Does fluoxetine aggravate Parkinson's disease ? A pilot prospective study
001743	O. Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France]	Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease
001791	O. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; N. Fabre [France] ; J. M. Senard [France] ; J. L. Montastruc [France] ; P. Calsis [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France]	Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa
001792	O. Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol	Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease
001900	N. Fabre [France] ; J. L. Montastruc ; O. Rascol	Alopecia : an adverse effect of bromocriptine
001A62	O. Rascol ; N. Fabre ; H. Teraêvaêinen ; Werner Poewe [Autriche] ; C. Luêcking ; U. Rinne ; E. Dupont ; D. Hirt ; M. Hoyer ; X. Lataste	CQA 206-291 : a novel dopamine agonist in the treatment of Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024